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ABSTRACT 
Short single-walled carbon nanotubes (SWNTs) functionalized by PEGylated phospholipids are biologically 
non-toxic and long-circulating nanomaterials with intrinsic near infrared photoluminescence (NIR PL), characteristic 
Raman spectra, and strong optical absorbance in the near infrared (NIR). This work demonstrates the first dual 
application of intravenously injected SWNTs as photoluminescent agents for in vivo tumor imaging in the 
1.0–1.4 μm emission region and as NIR absorbers and heaters at 808 nm for photothermal tumor elimination at 
the lowest injected dose (70 μg of SWNT/mouse, equivalent to 3.6 mg/kg) and laser irradiation power 
(0.6 W/cm2) reported to date. Ex vivo resonance Raman imaging revealed the SWNT distribution within tumors 
at a high spatial resolution. Complete tumor elimination was achieved for large numbers of photothermally 
treated mice without any toxic side effects after more than six months post-treatment. Further, side-by-side 
experiments were carried out to compare the performance of SWNTs and gold nanorods (AuNRs) at an 
injected dose of 700 μg of AuNR/mouse (equivalent to 35 mg/kg) in NIR photothermal ablation of tumors in 
vivo. Highly effective tumor elimination with SWNTs was achieved at 10 times lower injected doses and lower 
irradiation powers than for AuNRs. These results suggest there are significant benefits of utilizing the intrinsic 
properties of biocompatible SWNTs for combined cancer imaging and therapy. 
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1. Introduction 
Single-walled carbon nanotubes (SWNTs) have shown 
promise for biological applications [1] due to their ability 
to load targeting ligands [2] and chemotherapy agents 
[3, 4]. By virtue of their high optical absorbance in the 
biological transparency window of ~0.8–1.4 μm, SWNTs 
may also act as photothermal therapy agents [5, 6]. 
The intrinsic optical properties of SWNTs, such as 
strong resonance Raman scattering and near infrared 
photoluminescence (NIR PL) in the 1.1–1.4 μm spectral 
region, make them useful biological imaging agents 
[7–15]. Imaging of nanoparticle uptake into tumors, 
through the enhanced permeability and retention 
(EPR) effect [16], is key to nanomaterial-based cancer 
therapeutics. Nanoparticles, such as nanotubes and gold 
nanoparticles, have been used as NIR contrast agents 
[17, 18]. Previously, ex vivo and in vivo spectroscopy, 
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such as Raman scattering, have both been used to 
evaluate SWNT uptake [2, 13]. Other in vivo methods 
have also been utilized, such as positron emission 
tomography (PET) for radio-labeled nanotubes [2]. 
Photoacoustic imaging [19] was used to monitor SWNT 
tumor uptake in vivo, but whole animal imaging has  
not been accomplished. 
The inherent NIR PL of semiconducting SWNTs has 
proven useful as a biological imaging modality, due 
to the excitation being in the biological transparency 
window [18], the large Stokes shift between excitation 
and emission, and ultralow autofluorescence back- 
ground and deep tissue penetration in the emission 
range (1.1–1.4 μm) [14, 15, 20]. SWNTs have been used 
as PL imaging tags inside macrophage cells [8] and in 
Drosophila melanogaster (fruit flies) in vivo [10] based on 
their NIR PL. The ability to use SWNTs as fluorescent 
agents for targeted in vitro cell imaging with high 
specificity has been demonstrated [12]. The intrinsic 
photoluminescence of SWNTs has also been shown 
to be viable for whole body imaging and intravital 
tumor vessel imaging in vivo following intravenous  
injection [15]. 
A related area of research is photothermal therapy. 
When photosensitizers accumulate in close proximity 
in the body, a light source can be used to heat tissue 
to a level which results in photocoagulation and cell 
death [21]. Usually, this technique is used to reduce the 
size of, or eliminate, tumors. It has been difficult to 
find a method that achieves high tumor accumulation 
of the photosensitizers without direct injection into 
the tumor. Novel nanomaterials have shown promise 
for photothermal therapy due to their unique size and 
optical properties. Work has been done exploring 
nanomaterials as viable photothermal agents, such as 
gold nanoshells [21–24], gold nanorods (AuNRs) 
[25–28], gold nanopyramids [29], multi-walled carbon 
nanotubes (MWCNTs) [30], and SWNTs [31–33]. In vivo 
work has been done with intra-tumor injections of 
SWNTs, followed by excitation and heating by either 
radio frequencies or a NIR laser [6, 31, 33]. Intra-tumor 
injections require prior knowledge of the location of 
the tumor, whereas intravenous injection of a material 
with imaging and photothermal capabilities and high  
tumor uptake does not. 
Here, we demonstrate high tumor uptake of SWNTs 
with passive (non-targeted) accumulation following 
intravenous (i. v.) injection, and elimination of tumor 
masses with unprecedented low NIR laser powers of 
only 0.6 W/cm2. We also demonstrate the first NIR 
imaging of tumors using semiconducting SWNTs as 
photoluminescent agents in vivo. Tumor uptake of 
nanotubes is assessed in vivo using whole animal 
imaging of the NIR PL intrinsic to SWNTs. Following 
imaging, we utilize the high optical absorbance of the 
SWNTs to photothermally heat whole tumors, reaching 
a temperature (~52 °C) that leads to complete tumor 
destruction. In a comparative study, SWNTs exhibited 
higher tumor photoablation ability than AuNRs. While 
SWNTs at an injected dose of 3.6 mg/kg afforded 
tumor NIR ablation at a power of 0.6 W/cm2, AuNRs, 
at an injected dose of ~35 mg/kg, required a power  
of 2 W/cm2 for tumor elimination. Throughout the 
treatment process, no toxicity of the SWNTs was 
observed in vivo. These results demonstrate the high 
performance of SWNTs for in vivo tumor imaging 
and photothermal therapy without obvious toxic side  
effects. 
2. Experimental 
2.1 Functionalized carbon nanotubes and gold  
nanorods 
In a typical experiment, HiPco SWNTs were functiona- 
lized and solubilized by a mixture of 50% 1,2-distearoyl- 
phosphatidylethanolamine-methyl-polyethyleneglycol 
(DSPE-mPEG) [1, 2] and 50% C18-PMH-mPEG 
surfactants (Fig. 1(a)). C18-PMH-mPEG, (poly(maleic 
anhydride-alt-1-octadecene)-poly(ethylene glycol) 
methyl ether), is a PEG-branched polymer capable of 
binding to SWNTs and affording ultralong blood 
circulation of nanotubes (half-life ~18.9 h) [34]. The 
resulting suspension was centrifuged at 22 000 g for 
6 h to remove large aggregates and nanotube bundles 
[35]. The average length of the SWNTs was ~140 nm 
as determined by atomic force microscopy (AFM) 
(Fig. 1(c), Fig. S-2 in the Electronic Supplementary 
Material (ESM)). The NIR PL was characterized by 
photoluminescence excitation and emission (PLE) 
spectroscopy (Fig. 1(b)). The spots in the PLE map 
(Fig. 1(b)) correspond to excitation and emission of  
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individual SWNTs with different chiralities [36]. 
Gold nanorods (AuNRs) were prepared via seed- 
mediated growth in cetyltrimethylammonium bromide 
(CTAB) as described previously [37]. The CTAB 
coating on the AuNRs was exchanged for a methyoxy- 
terminated, thiolated poly(ethylene glycol) (mPEG-SH) 
coating (Fig. 1(d)) and the solution concentrated to 
3.5 mg/mL prior to injection, after removal of excess 
mPEG-SH by centrifugal filtration (molecular weight 
cut off (MWCO) 30 kDa). The size and shape of the 
AuNRs was confirmed by transmission electron micros- 
copy (TEM, Fig. 1(e)). At the same mass concentration 
(0.35 mg/mL), SWNTs exhibited a three-fold higher 
optical absorbance at 808 nm, which is the wavelength 
commonly used for NIR heating using nanomaterials  
(Fig. 1(f)). 
 
Figure 1 Nanotubes and nanorods for biological applications. (a) Schematic illustration of the surface functionalization of an SWNT
by C18-PMH-mPEG and phospholipid DSPE-mPEG in a solubilized suspension. Inset: photo of a stable suspension of functionalized
SWNTs in water. (b) PLE spectrum of a SWNT suspension. Individual peaks correspond to semiconducting SWNTs with different chirality.
(c) An AFM topography image of SWNTs. The height variation along the nanotubes in the AFM likely reflects the large differences in size
of the mixed surfactants used (C18-PMH- mPEG and DSPE-PEG have molecular weights of ~1 MD and 5 kD respectively). (d) Schematic
illustration of gold nanorods (AuNR) functionalized by mPEG-SH (5000 D). (e) A TEM image of AuNRs. Inset: photo of a stable suspension
of functionalized AuNRs in water. (f) UV–vis–NIR absorption curves of SWNTs and AuNRs at an equal mass concentration of 0.35 mg/mL.
A scatter component is superimposed for both nanoparticles 
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2.2 Tumor imaging using the intrinsic photo-  
luminescence of SWNTs 
Tumor-bearing mice were obtained by subcutaneous 
inoculation of ~2 million 4T1 murine breast tumor 
cells in BALB/c mice (Fig. S-2(a) in the ESM). For 
imaging, the typical SWNT injection dose was 200 μL 
of SWNTs at a concentration of 0.35 mg/mL through 
i. v. injection, corresponding to a dose of 3.6 mg/kg of 
mouse body weight. Different amphiphilic polymer 
coatings used to suspend SWNTs greatly affect their 
circulation time and biodistribution [38], including 
tumor uptake. By measuring the intrinsic Raman 
signals of SWNTs in blood and various organs (see the 
Methods section) [38], we found that the 50% DSPE- 
mPEG/50% C18-PMH-mPEG coating gave SWNTs 
with a long blood circulation half-life of 6.9 h (Fig. 2(a)) 
and high tumor uptake of 8% ID/g (injected dose/gram 
of tissue), despite high uptake in the liver and spleen  
(Fig. 2(b)). 
We were able to monitor SWNT fluorescence in vivo 
over the course of two days using a 2D InGaAs detector 
(n > 10) (Figs. 2(c) and 2(d)). Very low autofluorescence 
was observed from untreated mice in the collection 
window (1.1–1.7 μm) [14, 15] (see Fig. S-2(b) in the 
ESM). Following injection of SWNTs, the vessels of 
the mouse were brightly fluorescent in the 1.1–1.4 μm 
range, as the SWNTs were circulating in the blood 
(Fig. S-2(c)). At 6-h post-injection (Fig. S-2(d)), tumor 
accumulation was already evident. After 1 day, the 
majority of SWNTs were cleared from the blood and 
the high tumor uptake became evident from the  
high tumor contrast in the NIR fluorescence images 
(Fig. 2(d), Figs. S-1(e) and S-1(f)), consistent with the 
ex vivo biodistribution data (Fig. 2(b)). Several dozen 
mice were imaged during the course of this study and 
all showed high tumor uptake of SWNTs which resulted 
in easy imaging of tumors by using the intrinsic NIR  
photoluminescence of nanotubes. 
Additionally, we conducted confocal Raman imaging 
of thin (10 μm) slices of tumor tissues obtained 3 days 
post-injection of SWNTs. We used the characteristic 
graphitic (G) band (Fig. 2(f)) of the SWNT at ~1600 cm–1 
to map out the concentration of SWNTs at a given 
point in the tissue slice [11], allowing us to glean the 
exact distribution of SWNTs within the tumor with a 
spatial resolution of ~20 μm (Fig. 2(e)). The Raman 
imaging revealed an appreciable amount of SWNTs 
deep inside the tumor, in addition to SWNTs on the 
outer edge of the tumor (Fig. 2(e)). Raman imaging  
is another important feature of SWNTs owing to 
strong resonance Raman effects in one-dimensional  
systems [1]. 
2.3 Photothermal treatment of tumors with SWNTs 
and AuNRs 
Twenty BALB/c mice were inoculated with one 
subcutaneous 4T1 tumor each over the right shoulder, 
directly beneath the skin. Five days after the inoculation, 
10 of the mice were injected intravenously with 200 μL 
of a 2 μmol/L (0.35 mg/mL) solution of SWNTs with a 
50% DSPE-mPEG/50% C18-PMH-mPEG coating [5]. 
This was approximately a 3.6 mg/kg body weight dose 
of SWNTs. Three days after injection, all mice were 
irradiated for 5 min at 0.6 W/cm2 with an 808 nm NIR 
laser with a laser spot size of 4.4 cm2 (Fig. 3). The laser 
power was kept constant throughout the irradiation. 
This led to a rapid temperature rise in the first  
minute which then leveled to approximately 52–54 °C 
over the next four minutes. The temperature was 
monitored continuously by thermal imaging and 
checked periodically by a thermoprobe placed directly 
in contact with the tumor. The physical appearance 
of the tumor whitened. The tumors had an average 
size of ~22 mm3 at the start of irradiation. Thermal 
images, taken at various time points during the heating, 
showed that tumors on non-injected mice heated up 
very slowly and reached an average temperature of 
43 °C (Fig. 3(b)). In contrast, the tumors of SWNT- 
injected mice reached temperatures of 52.9 °C after 
5 min of irradiation (Fig. 3(a)) under the same con- 
ditions (n = 10). Overall, while the laser spot size was 
much larger than the tumor (4.4 cm2 as compared to a 
tumor size of less than 0.5 cm2), thermal imaging 
indicated that the healthy, illuminated tissue of SWNT- 
injected mice remained closer to normal body tem- 
peratures (Fig. 3(a)). This confirms that SWNTs taken 
up by tumors were responsible for the absorption of 
laser light, and subsequent heating of the tumor tissue. 
After treatment, the tumors in the mice injected with 
SWNTs turned black. Eventually this led to an eschar  
forming over the top of the tumor. 
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Figure 2 In vivo NIR imaging using carbon nanotube photoluminescence. (a) SWNT blood circulation data. Black symbols correspond to
experimental data. The red line is a first order exponential fit to the data, indicating a half-life of approximately 6.9 h. After 48 h, the
SWNT signal had dropped below the detection limit. These data were obtained by Raman spectroscopy (see the Methods section). Error
bars are based on three mice per group. (b) Biodistribution of SWNTs in various organs. Three mice were sacrificed 48 h after injection.
The SWNT concentration was measured using Raman spectroscopy (see the Methods section). (c) Optical image of a BALB/c mouse
with two 4T1 tumors (indicated by arrows). (d) An NIR PL image taken 48 hours post-injection. High tumor contrast is seen as the SWNTs
are cleared from blood circulation, leaving SWNTs passively taken up in the tumors through the enhanced EPR effect. (e) A Raman image
(the green color represents the intensity of the Raman G band of SWNTs) showing the distribution of SWNTs in a 10 μm thin slice of
tumor. Mice were sacrificed three days post-injection and Raman mapping was performed using Raman spectroscopy with 20 μm step
size (see the Methods section ). (f) A Raman spectrum of a SWNT solution. Note the strong characteristic G peak of at 1600 cm–1 which
is used for Raman imaging 
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After the skin over the treated area on SWNT- 
injected, NIR irradiated mice had healed—which 
occurred on average about two weeks after the 
heating—no tumor remained. The only indication of 
any tumor was a small scar. In contrast, the mice in the 
control NIR radiation group without SWNT injection 
did not show any sign of tumor damage. All tumors 
in the control group continued to grow (Fig. 4(a)), and 
by the 36th day after heating, all mice in the control 
group were considered “non-survival” due to their large 
tumor size (>0.5 cm3, Fig. 4(b)). In strong contrast,  
all ten of the mice in the SWNT-injected NIR laser 
treated group were considered surviving without any 
tumor re-growth ~6 months post-treatment (Figs. 4(a)  
and 4(b)). 
For comparison, we examined the NIR photothermal 
heating capabilities of AuNRs with a longitudinal 
plasmon resonance near 808 nm (Figs. 1(e) and 1(f)). 
The absorption coefficient for SWNTs at 808 nm is 
46.5 L/(g·cm) [38]. Based on the UV–Vis spectrum, 
the absorption coefficient for AuNRs at 808 nm is 
13.89 L/(g·cm). Five mice bearing two tumors each 
were injected intravenously with 200 μL of the AuNRs 
at a dose of ~35 mg/kg, and the AuNRs were allowed 
to circulate and distribute for 48 h. We found that 
AuNRs, while able to heat and ablate tumors at the 
previously reported power levels of 2 W/cm2 of 808 nm 
laser irradiation [27, 29] for 5 min, were not able to 
significantly heat or damage tumors when they were 
illuminated with NIR laser light with a power of only 
0.6 W/cm2 for 5 minutes (Figs. 5(a)–5(c)). The tumors 
heated at 2 W/cm2 formed an eschar and diminished 
while the tumors heated at 0.6 W/cm2 continued to 
grow unabated (Fig. 5(d)). Based on thermal imaging, 
the average temperature of tumors in mice that were 
injected with AuNRs and heated at 2 W/cm2 for 
 
Figure 3 Thermal imaging of a tumor during photothermal treatment. (a) A thermal image of a tumor-bearing mouse injected with
200 μL of 0.35 mg/mL (3.6 mg/kg) solubilized SWNT solution under 808 nm laser irradiation. The therrmal image was taken 4.5 min
into NIR laser irradiation of the tumor and surrounding area at a power of 0.6 W/cm2. Nine mice injected with solubilized SWNTs were
thermally imaged while being irradiated, all showing similar results. The temperature rise in the skin surrounding the tumor was below
the temperature threshold for tissue damage and no skin damage in the near or long term was observed. (b) A thermal image of a control
tumor-bearing mouse without SWNT injection. The therrmal image was taken 4.5 min into 808 nm NIR laser irradiation of the tumor
and surrounding area at a power of 0.6 W/cm2. (c) Optical image of the BALB/c mouse in (a) injected with SWNTs, immediately before
NIR laser irradiation. (d) Optical image of the mouse in (b) taken immediately before NIR laser irradiation. The arrows point to the
subcutaneous tumor in the mouse 
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5 min was much greater (~50 °C) than that of tumors 
heated at 0.6 W/cm2 (~40 °C). Our data is consistent 
with the best result achieved previously by photo- 
ablation with AuNRs [26, 28], i.e., in vivo tumor 
destruction was also observed at a NIR laser power 
of ~2 W/cm2 with a similar injected dose of AuNRs to  
that used here. 
In our study, no mice that had been injected with 
SWNTs and exposed to NIR laser irradiation showed 
any weight loss or signs of distress (Fig. 4(c)). 48 days 
after photothermal treatment, blood was collected from 
the ten SWNT-treated mice and from five untreated, 
healthy control mice for analysis. All blood panel values 
for the treated mice fell within the previously reported 
normal range for healthy BALB/c mice [39] and matched 
well with those of healthy, untreated animals (see  
 
Figure 4 Complete tumor elimination by photothermal treatment with SWNTs. (a) Plot of relative tumor volume vs. time for control
group (10 mice) not injected with SWNTs but laser irradiated at 808 nm with 0.6 W/cm2 power for 5 min, control group (four mice) that
were injected with SWNTs but received no NIR laser irradiation, and treatment group (10 mice) injected with SWNTs and laser
irradiated at 808 nm with 0.6 W/cm2 power. Injection of 200 μL of 0.35 mg/mL (3.6 mg/kg) solubilized SWNT solution occurred on day
0 and NIR laser irradiation occurred on day 3. (b) Survival curve of control (no SWNT injection, laser irradiated at 808 nm with
0.6 W/cm2 power) group (10 mice) vs. the treated (SWNT injection, laser irradiated at 808 nm with 0.6 W/cm2 power) group (10 mice).
Mice were deemed “non-survival” once the tumor volume exceeded 500 mm3. No mice from the control group survived past 30 days
post-treatment. All mice from the treatment group were surviving and tumor-free at the end of two months.  (c) Normalized body
weight for various mouse groups in (a). No mice in any group experienced significant weight loss (greater than 10%) during the study 
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Figure 5 In vivo photothermal treatment of tumors with gold nanorods: (a) a thermal image of a mouse bearing two tumors injected 
with 200 μL of 3.5 mg/mL (35 mg/kg) AuNR solution, taken of the left shoulder tumor 4.5 min into NIR laser irradiation at a power of
2 W/cm2; (b) a thermal image of the same mouse as in (a) injected with 200 μL of 3.5 mg/mL (35 mg/kg) AuNR solution, taken of the 
right shoulder tumor 4.5 min into NIR laser irradiation at a power of 0.6 W/cm2; (c) an optical image of the same BALB/c mouse as in 
(a) and (b) taken immediately before NIR laser irradiation; (d) plots of relative tumor volume vs. time for AuNR injected mice for 
tumors heated at 0.6 W/cm2 for 5 min (five mice/group) and tumors heated at 2 W/cm2 for 5 min (five mice/group) 
 
Figure 6 Histology staining of the organs of mice injected with SWNTs after long-term exposure. Photomicrographs of hematoxylin and 
eosin (H&E)-stained (a) spleen, with white pulp (w. p.) and red pulp (r. p.); (b) liver; (c) lung; and (d) haired skin from mice 144 days 
after injection of SWNTs. Note that all organs appeared histologically normal. Notice the presence of dull to dark gray-brown, finely 
granular, intracytoplasmic pigment (indicated by black arrows) within scattered macrophages of the liver and spleen. This 
intracytoplasmic pigment is distinct from the variably-sized, brown to golden-brown hemosiderin pigment noted in other parts of the 
red pulp of the spleen, and is interpreted as residual SWNTs within macrophages with long life spans in the liver and spleen. The lack 
of organ or tissue damage observed by histologic evaluation, combined with the normal blood biochemical data and lack of obvious
behavioral or body weight changes, suggests the overall non-toxic nature of the SWNTs 
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Table S-1 in the ESM). The excretion pathway for 
SWNTs solubilized by amphiphilic polymers has 
previously been shown to be through the biliary 
pathway [38]. Our biodistribution data showed high 
signals of SWNTs in the liver as well as in the 
intestine 48 h after injection (Fig. 2(b)), consistent 
with fecal excretion of SWNTs [38]. In order to ascertain 
the long term toxicity of the solubilized SWNTs, three 
mice from the treatment group were submitted for 
histology 144 days after injection of SWNTs (Fig. 6) 
Additionally, a blood chemistry panel was performed 
on five mice 163 days post-injection (see Table S-1 in 
the ESM). Both histology and blood chemistry data 
suggested healthy normal functions of the treated  
mice. 
3. Discussion 
Our SWNTs (average length~140 nm), with appropriate 
chemical functionalization, afforded high passive 
accumulation in tumors relative to surrounding organs 
and provide an opportunity to combine imaging and 
photothermal therapy of tumors by utilizing the 
intrinsic optical properties of nanotubes. The inherent 
characteristic Raman bands and NIR PL of SWNTs 
allow for both in vivo and ex vivo tracking and imaging. 
Monitoring the fluorescence of the SWNTs gives 
unambiguous confirmation of SWNT uptake by the 
tumors. The fact that photoluminescence of SWNTs 
in the tumor was clearly present and can be used  
for tumor imaging suggests a lack of significant 
aggregation of nanotubes in the tumor, since this 
would cause quenching of the photoluminescence of 
the nanotubes [36]. Whole body NIR fluorescence 
imaging allows visualization of the preferential tumor 
accumulation of SWNTs (Fig. 2(d), Fig. S-2 in the ESM). 
SWNTs are interesting as NIR fluorescent probes  
due to their unusual emission range of 1.0–1.4 μm 
(Fig. 1(b)), which is ideal for biological imaging due 
to the inherently low autofluorescence in this region 
[14, 15]. The large Stokes shift between excitation and 
emission bands of SWNTs allows for excitation in the 
biological transparency window near 800 nm, while 
detecting and imaging with reduced background from 
autofluorescence and scattering in the 1.0–1.4 μm 
region [14, 15]. Also, NIR fluorophores with emission  
in the 1.0–1.4 μm range have higher tissue penetration 
than those with emission near 800 nm, considering the 
effects of scattering by tissue. Thus, despite relatively 
low PL quantum yield of SWNTs (<1%–2%) [14, 15], 
the ultralow imaging background and sufficient 
tissue penetration afford excellent contrast for SWNT 
photoluminescence agents when imaging subcutaneous  
tumors in mice.  
The depth penetration of the NIR laser does become 
an issue when treating tumors deep within the body. 
Since the penetration depth is less than 1 cm, other 
methods besides an external laser source must be 
devised in order to effectively treat deep body tumors. 
This could be resolved through the use of an internal  
fiber optic laser source threaded into the body [40].  
When the NIR fluorescence images show a high 
signal in the tumor and a low signal in the surrounding 
tissue, we are able to heat the tumors without incurring 
damage to healthy tissue. Never before have SWNTs 
been intravenously (i. v.) injected, imaged in the 
tumor by their intrinsic photoluminescence and 
subsequently heated by NIR irradiation. To demon- 
strate the effectiveness and benefit of SWNTs relative 
to other materials, we compared the photothermal 
therapy capability of commonly used AuNRs with 
that of SWNTs. At the same mass concentration of 
0.35 mg/mL, SWNTs exhibited an optical absorbance 
at 808 nm which was 328% greater than that of AuNRs 
(Fig. 1(f)). The AuNRs exhibited a strong optical 
absorption at 808 nm due to plasmonic resonance; the 
wavelength of this absorption is tunable by varying the 
aspect ratio and size [41]. The high NIR absorbance of 
SWNTs originates from their one-dimensional 
electronic structures. Note that the SWNTs used here 
contain many different chiralities, each of which  
has peaks of absorption and emission at different 
wavelengths [36] (Fig. 1(b)). Therefore, only a few 
chiralities of SWNTs in our current sample have an 
absorption peak at 808 nm in resonance with the 808 nm 
laser. With advances in chirality separation techniques, 
we will be able to use a selected single-chirality SWNT 
with greatly increased optical absorbance to afford 
higher photothermal efficiency at a further reduced 
injection dose. With chirality-separated materials, 
tumor targeting to increase tumor uptake, and optimal 
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surface coating for long blood circulation and high 
tumor uptake, the injection dose needed for SWNTs  
to achieve tumor ablation could be further lowered 
from the currently lowest reported level of 3.6 mg/kg  
demonstrated here.  
It should also be noted that compared to previous 
literature results, our SWNT photothermal treatment 
affords highly effective tumor destruction at much 
lower injected doses and laser irradiation power than 
other photothermal therapy agents reported, including 
gold nanoshells, nanorods and multi-walled nanotubes 
(see Table S-2 in the ESM). For SWNTs, 100% tumor 
destruction was achieved with a dose which was 
only 10%, and a laser irradiation power which was 
only 30%, of the corresponding values required to 
achieve 100% tumor destruction with Au nanorods It 
should be noted that the laser irradiation power (0.6 
W/cm2) and exposure time used here for SWNTs are 
slightly above the laser safety standards for humans. 
The maximum skin exposure for a continuous wave 
808 nm laser, based on the American National Standard  
for the Safe Use of Lasers, is ~0.33 W/cm2.  
Both AuNRs [26] and SWNTs when properly 
functionalized have long blood circulation times and 
upon intravenous injection accumulate in tumors 
through the EPR effect. For both materials, highly 
hydrophilic poly(ethylene) glycol (PEG)-based polymers 
are used as a “masking” device in vivo, coating both 
AuNRs and SWNTs to avoid rapid attack by the 
body’s immune system. Toxicity and long term 
retention/excretion is a concern for all nanomaterials 
in vivo. The extent of acute or long-term toxicity of 
carbon nanotubes is currently under investigation. 
Our short SWNTs coated by phospholipids have high 
solubility and stability against agglomeration in 
aqueous solutions and serum and have been demon- 
strated to be biocompatible and non-toxic to mice over  
a monitoring period of up to six months [38, 42].  
Stable PEGylated SWNTs do not seem to damage 
mice organs after i. v. injection and the majority appear 
to be excreted from the body over the course of   
< two months [38, 42]. Results from the current work 
(Table S-1 in the ESM) further confirm non-toxicity of 
our SWNTs in vivo. Histology was conducted on the 
vital organs of the mice in the treatment group 144 
days after injection of solubilized SWNTs (Fig. 6). No 
pathology or cancer was observed and the organs 
were all in healthy condition. Small amount of SWNTs 
appeared to be still retained in the macrophage cells 
of the liver and spleen as shown by the dull grey 
pigmentation seen in stained slices of these organs 
(Figs. 6(b) and 6(c)). However, no damage was seen in 
any of the tissues examined and the residual SWNTs 
did not cause any loss of function of the spleen or 
liver. Furthermore after observation for 144 days, 
despite the highly metastatic nature of 4T1 tumors, 
no metastases were observed in any of the mice in 
the treatment group. Based on the biodistribution 
data (Fig. 2(b)), as long as NIR light irradiation 
avoids the reticuloendothelial system (RES) organs 
(including liver and spleen that have high SWNT 
uptake) during tumor irradiation, few side effects and  
little organ damage is expected. 
Longer term effects should be investigated (currently 
underway in our laboratory) to ensure the complete 
biocompatibility of PEGylated SWNTs. Note that 
possible toxicity effects of gold nanomaterials have also 
been under examination. Gold nanoshell photothermal 
cancer treatment is already in Phase I clinical trials 
[43]. AuNRs coated by CTAB, while toxic in vivo and 
in vitro, are non-toxic when exchanged with more 
biocompatible coatings [44]. AuNRs exchanged from 
CTAB to a mPEG-SH coating have been shown to be 
non-toxic in the short term in vivo [26, 28]. To our 
knowledge, the long term fate, excretion, and toxicity 
of intravenously injected gold nanomaterials have 
not yet been reported. The long term fate and toxic 
effects for various nanomaterials require systematic 
investigation. The benefits and risks of these materials  
for potential future clinic use can then be assessed. 
4. Conclusions 
In vivo photothermal laser heating of tumors coupled 
with the ability to image and visualize their uptake 
into tumors makes SWNTs a promising potential 
material for future photothermal treatment. The 
novelty of the current work lies in several areas. On 
the imaging front, we have been able to achieve high 
tumor uptake of SWNTs, and used the intrinsic NIR 
PL of SWNTs for tumor imaging for the first time. 
With regards to treatment, we took advantage of the  
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high optical absorbance of SWNTs in the NIR to heat 
tumor masses to the point of complete cell death, using 
lower power (0.6 W/cm2) than previously reported at 
injection doses as low as 3.6 mg/kg. The ability to 
faithfully track the tumor distribution of SWNTs 
from their Raman signal is also an important feature 
of SWNTs. In order to put the efficiency of SWNTs   
in perspective, we conducted a comparative study 
with AuNRs. Further improvement, such as chiral 
separation of SWNTs, could lead to a significantly 
lower injection dose and lower laser powers needed 
for tumor destruction. Continued investigation of the 
toxicity, if any, of well-coated SWNTs employed in 
cancer therapy is important as well. Nevertheless, the 
ability to image SWNTs within the body of live mice 
and the high performance of SWNTs in photothermal 
therapy for tumor elimination lays the groundwork 
for future experimentation into using the inherent pro-  
perties of SWNTs for cancer detection and treatment.  
5. Methods 
5.1 Materials  
HiPco single-walled carbon nanotubes were obtained 
from Carbon Nanotechnologies Inc. Poly(maleic 
anhydride-alt-1-octadecene) (molecular weight 30 to 
50 kDa) was purchased from Sigma-Aldrich. Both 
mPEG-NH2 and DSPE-mPEG were obtained from 
Laysan Bio Inc. Regenerated cellulose dialysis mem-  
brane bags were obtained from Fischer Scientific. 
5.2 Synthesis of C18-PMH-mPEG 
Polymer C18-PMH-mPEG was synthesized in the 
following manner based on previous work [34]. 
Methoxy-poly(ethylene glycol)-amine (285.7 mg, 
0.05714 mmol, mPEG-NH2, 5 kDa) was combined 
with poly(maleic anhydride-alt-1-octadecene) (10 mg, 
0.0286 mmol) in 15 mL of a 9:1 DMSO/pyridine mixture. 
The solution was allowed to stir for 12 h at room 
temperature, followed by the addition of 1-ethyl-3- 
(3-dimethylaminopropyl) carbodiimide hydrochloride 
(21.8 mg, 0.11 mmol) (EDC·HCl). The reaction was 
continued for 24 h, followed by dialysis to remove  
excess mPEG-NH2. 
5.3 Preparation of SWNT suspensions 
A 50% DSPE-mPEG/50% C18-PMH-mPEG SWNT 
nanotube solution was prepared by combining 
0.2 mg/mL of HiPco tubes with 0.6 mg/mL of DSPE- 
mPEG and 0.6 mg/mL of C18-PMH-mPEG in 30 mL of 
water. The solution was sonicated for 1 h followed by 
centrifugation (6 h, 22 000 g) to remove any bundles 
or aggregates. The resulting supernatant was collected 
and filtered eight times through a 100 kDa pore size 
filter (Millipore) to remove excess polymer. 200 μL 
solutions of 2 μmol/L SWNT were prepared in 2× 
phosphate-buffered saline (PBS). This was done by 
adjusting the concentration based on the absorption 
peak at 808 nm having an extinction coefficient [5] of  
7.9 × 106 L/mol cm. 
5.4 Synthesis of gold nanorods (AuNRs) 
Gold nanorods (AuNRs) were prepared via seed- 
mediated growth in cetyltrimethylammonium bromide 
(CTAB, Sigma-Aldrich) as described previously [37] 
and reacted with methyoxy-terminated, thiolated 
poly(ethylene glycol) (mPEG-SH, 5 kDa, Laysan Bio) 
to provide biocompatible AuNRs with a longitudinal 
surface plasmon centered at ~800 nm. 5 mL of 
0.2 mol/L CTAB was mixed with 5 mL of 0.5 mmol/L 
HAuCl4 (Sigma-Aldrich, 99.9%), and the Au(Ⅲ) was 
reduced to form seed particles with 600 μL of ice-cold 
10 mmol/L NaBH4, yielding a yellow–brown solution. 
The AuNR growth solution was prepared by adding 
80 mL of 0.2 mol/L CTAB to 3.2 mL of 4 mmol/L AgNO3, 
followed by addition of 80 mL of 1 mmol/L HAuCl4 
and finally 1.12 mL of 78.8 mmol/L ascorbic acid, 
yielding a colorless solution. 192 μL of seed solution 
was added to the growth solution, facilitating AuNR 
growth over the course of several hours at 25 °C. To 
exchange the CTAB coating by mPEG-SH, 40 mL of 
as-made AuNRs were centrifuged at 22 000 g for 7 min 
and the supernatant was discarded. The AuNRs  
were resuspended in 15 mL of deionized water, and 
mPEG-SH was added to give a final concentration of 
250 μmol/L. After gentle agitation at room tem- 
perature for one hour, the solution was added to a 
pre-soaked regenerated cellulose dialysis membrane 
(MWCO 3500 Da, Fisher), and dialyzed against 5 × 1 L 
deionized water. Excess mPEG-SH and any residual 
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CTAB were then removed by 4× centrifugal filtration 
in water (Millipore Amicon Ultra, 30 kDa MWCO), 
which also allowed concentration of the AuNR sample  
prior to injection.  
5.5 Photoluminescence excitation and emission  
Spectra (PLE)  
PLE spectra were recorded on a homebuilt NIR 
spectroscopy setup. The excitation source was a 150 W 
ozone-free xenon lamp (Oriel) which was dispersed 
by a monochromator (Oriel) to produce excitation 
lines with a 15 nm bandwidth. The excitation light 
was focused onto a 1 mm quartz cuvette containing 
the sample. Emission was collected in transmission 
geometry. The excitation light was rejected using an 
850 nm long-pass filter (Omega). The emitted light was 
directed into a spectrometer (Acton SP2300i) equipped 
with a liquid nitrogen cooled InGaAs linear array 
detector (Princeton OMA-V). Spectra were corrected 
post-collection to account for the sensitivity of the  
detector and the power of the excitation. 
5.6 Mouse handling and injection for imaging 
Female BALB/c mice obtained from Charles Rivers 
were housed at Stanford Research Animal Facility 
(RAF) under Stanford Institutional Animal Care and 
Use Committee (IACUC) protocols. Six mice had 
their backs shaved and were injected bilaterally with 
~2 million 4T1 tumor cells on both shoulders. The 
tumors were allowed to grow for 5 days to a size 
approxi- mately 3–6 mm in length and width. After 
this time, the mice were anesthetized with isoflurane 
gas and an optical image along with a NIR PL image 
was taken. A solubilized SWNT solution was tail vein 
(intravenously) injected into the six mice and NIR PL 
images were collected over the following 48 h. Three of 
the mice were used for circulation and biodistribution  
tests.  
5.7 Mouse handling and injection for treatment 
Female BALB/c mice obtained from Charles Rivers 
were housed at Stanford Research Animal Facility 
under Stanford Institutional Animal Care and Use 
Committee protocols. Twenty mice had their backs 
shaved and were injected bilaterally with ~2 million 
4T1 tumor cells on their right shoulders. Four mice had 
their backs shaved and were injected bilaterally with 
~2 million 4T1 tumor cells on both of their shoulders. 
5.8 NIR PL Imaging 
NIR PL images were collected using a 2-D liquid 
nitrogen cooled InGaAs detector (Princeton). A 20 W 
808 nm diode laser (RPMC) was used as the excitation 
source. The excitation power density at the imaging 
plane was 0.15 W/cm2. The excitation was shuttered 
so that the mice were only subjected to the excitation 
beam for the duration of the exposure time. Exposure  
time for all images shown was 300 ms. 
5.9 Blood Circulation 
Three mice were intravenously injected with 200 μL 
solutions of 2 μmol/L (0.35 mg/mL) SWNTs. At given 
time points, approximately 4 μL of blood was drawn 
from the tail of each mouse. The blood was mixed 
with 8 μL of tissue lysis buffer solution (1% SDS, 1% 
Triton X-100, 40 mmol/L Tris acetate, 10 mmol/L EDTA, 
10 mmol/L DTT). The height of the characteristic G peak 
in the Raman spectrum of the SWNTs corresponds 
directly to the concentration of SWNTs. This, when 
compared with the injected solution, allows us to 
quantify the amount of SWNTs still circulating in the  
blood as previously reported [38]. 
5.10 Biodistribution 
The mice used for circulation tests were sacrificed at 
48 h post-injection. Organs were collected and weighed, 
then dissolved in a known amount of tissue lysis buffer. 
The mixtures were made homogenous through heating 
and blending. After this, Raman spectroscopy was 
used in the same manner as for the blood circulation 
measurements to identify the concentration of 
SWNTs in the various organelles, as has been reported  
previously [38]. 
5.11 SWNT distribution in the tumors 
Three mice that had not been used in any other tests 
were inoculated with two 4T1 tumors bilaterally. Five 
days after inoculation, 200 μL of a solution of 2 μmol/L 
(0.35 mg/mL) of solubilized SWNTs was injected. 72 h 
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after injection, the mice were sacrificed and tumors 
were collected and frozen in Tissue-Tek OCT com- 
pound. The tumors were sliced into 10 μm thin layers 
and placed on quartz. Raman (LabRam 800 Horiba 
Jobin Yvon) mapping using 785 nm excitation was 
conducted with 20 μm steps, 0.1 s integration time, and 
five accumulations per point with an average laser spot  
size of ~1 μm2. 
5.12 NIR laser irradiation of tumors in mice 
Twenty four mice in total were included in the mouse 
heating study. Twenty mice had one tumor each while 
four mice had two tumors each. Ten of the twenty mice 
with one tumor were intravenously injected with 
200 μL aliquots of 2 μmol/L solubilized SWNTs five 
days after tumor inoculation. The four mice with two 
tumors each were intravenously injected with 200 μL 
of 2 μmol/L of solubilized SWNTs five days after tumor 
inoculation. Three days post-injection, all twenty four 
mice were anesthetized with isoflurane gas and 
exposed to 808 nm collimated laser light. The light was 
shone directly on the right shoulder for 5 min on a 
4.4 cm2 sized spot with a power of 0.6 W/cm2 (the four 
mice with bilateral tumors did not have any irradiation 
on the tumor located on the left shoulder). After this 
time, mice were monitored by body weight and 
tumor size every two days for the following 35 days 
(or until the tumor size exceeded the survival size of 
0.5 cm3). Five mice with two tumors each (5 days post 
inoculation) were injected with 200 μL of 3.5 mg/mL 
AuNR solution (35 mg/kg injection dose). 48 h after 
injection, the tumor on the right shoulder was irradiated 
with 808 nm laser light at a power of 0.6 W/cm2 for 
5 min. Afterwards, the tumor on the left shoulder was 
irradiated with 808 nm laser light at a power of 
2 W/cm2 for 5 min. Tumor growth was monitored for 
several weeks or until the tumor reached 0.5 cm3 in  
volume.  
5.13 Thermal imaging 
Thermal images were taken using a MikroShot camera 
(Mikron). During heating, thermal images were 
collected for mice before heating, and at 1, 2, and 
5 minutes into the heating process. Throughout heating, 
the temperature of the mouse tumors was monitored  
by the MikroShot camera. 
5.14 Histology and blood chemistry  
51 days after injection of SWNTs, blood was collected 
from ten injected/irradiated mice and five control mice. 
Blood was again collected from five injected/irradiated 
mice 163 days after injection of SWNTs. Blood was 
collected by retro-orbital bleeding and serum chemistry 
analyzed by the Diagnostic Laboratory, Veterinary 
Service Center, Department of Comparative Medicine, 
Stanford University School of Medicine. 144 days 
after injection of SWNTs, three mice that had been 
injected/irradiated were submitted for histology. A 
full necropsy was performed, and all internal organs 
were harvested, fixed in 10% neutral buffered formalin, 
processed routinely into paraffin, sectioned at 4 mm 
and stained with hematoxylin and eosin (H&E). The 
following tissues were examined by optical microscopy: 
liver, kidneys, spleen, heart, salivary gland, lung, 
trachea, esophagus, thymus, reproductive tract, urinary 
bladder, eyes, lymph nodes, brain, thyroid gland, 
adrenal gland, gastrointestinal tract, pancreas, bone 
marrow, skeletal muscle, nasal cavities, middle ear,  
vertebrae, spinal cord, and peripheral nerves. 
Acknowledgements 
This work was supported by Ensysce Biosciences, 
CCNE-TR at Stanford University and NIH-NCI RO1  
CA135109-02. 
Electronic Supplementary Material: Supplementary 
material detailing other properties of the photothermal 
agents, the complete time course of whole animal 
imaging, and blood chemistry data is available in the 
online version of this article at http://dx.doi.org/10.1007/  
s12274-010-0045-1 and is accessible free of charge. 
Open Access: This article is distributed under the terms 
of the Creative Commons Attribution Noncommercial 
License which permits any noncommercial use, 
distribution, and reproduction in any medium,  
provided the original author(s) and source are credited. 
 Nano Res 
 
14
References 
[1] Liu, Z.; Tabakman, S.; Welsher, K.; Dai, H. Carbon nanotubes 
in biology and medicine: In vitro and in vivo detection, 
imaging and drug delivery. Nano Res. 2009, 2, 85–120. 
[2] Liu, Z.; Cai, W.; He, L.; Nakayama, N.; Chen, K.; Sun, X.; 
Chen, X.; Dai, H. In vivo biodistribution and highly efficient 
tumor targeting of carbon nanotubes in mice. Nat. Nanotechnol. 
2007, 2, 47–52. 
[3] Liu, Z.; Chen, K.; Davis, C.; Sherlock, S.; Cao, Q.; Chen, 
X.; Dai, H. Drug delivery with carbon nanotubes for in vivo 
cancer treatment. Cancer Res. 2008, 68, 6652–6660. 
[4] Liu, Z.; Fan, A. C.; Rakhra, K.; Sherlock, S.; Goodwin, A.; 
Chen, X.; Yang, Q.; Felsher, D. W.; Dai, H. Supramolecular 
stacking of doxorubicin on carbon nanotubes for in vivo 
cancer therapy. Angew. Chem. Int. Edit. 2009, 48, 7668–7672. 
[5] Kam, N. W.; O’Connell, M.; Wisdom, J. A.; Dai, H. Carbon 
nanotubes as multifunctional biological transporters and near- 
infrared agents for selective cancer cell destruction. Proc. 
Natl. Acad. Sci. USA 2005, 102, 11600–11605. 
[6] Moon, H. K.; Lee, S. H.; Choi, H. C. In vivo near-infrared 
mediated tumor destruction by photothermal effect of 
carbon nanotubes. ACS Nano 2009, 3, 3707–3713. 
[7] Chen, Z.; Tabakman, S. M.; Goodwin, A. P.; Kattah, M. G.; 
Daranciang, D.; Wang, X.; Zhang, G.; Li, X.; Liu, Z.; Utz, 
P. J., et al. Protein microarrays with carbon nanotubes as 
multicolor raman labels. Nat. Biotechnol. 2008, 26, 1285–1292. 
[8] Cherukuri, P.; Bachilo, S. M.; Litovsky, S. H.; Weisman, R. 
B. Near-infrared fluorescence microscopy of single-walled 
carbon nanotubes in phagocytic cells. J. Am. Chem. Soc. 
2004, 126, 15638–15639. 
[9] Cherukuri, P.; Gannon, C. J.; Leeuw, T. K.; Schmidt, H. K.; 
Smalley, R. E.; Curley, S. A.; Weisman, R. B. Mammalian 
pharmacokinetics of carbon nanotubes using intrinsic near- 
infrared fluorescence. Proc. Natl. Acad. Sci. USA 2006, 103, 
18882–18886. 
[10]  Leeuw, T. K.; Reith, R. M.; Simonette, R. A.; Harden, M. 
E.; Cherukuri, P.; Tsyboulski, D. A.; Beckingham, K. M.; 
Weisman, R. B. Single-walled carbon nanotubes in the 
intact organism: Near-ir imaging and biocompatibility studies 
in drosophila. Nano Lett. 2007, 7, 2650–2654. 
[11]  Liu, Z.; Li, X.; Tabakman, S. M.; Jiang, K.; Fan, S.; Dai, H. 
Multiplexed multicolor raman imaging of live cells with 
isotopically modified single walled carbon nanotubes. J. Am. 
Chem. Soc. 2008, 130, 13540–13541. 
[12]  Welsher, K.; Liu, Z.; Daranciang, D.; Dai, H. Selective 
probing and imaging of cells with single walled carbon 
nanotubes as near-infrared fluorescent molecules. Nano Lett. 
2008, 8, 586–590. 
[13]  Keren, S.; Zavaleta, C.; Cheng, Z.; de la Zerda, A.; Gheysens, 
O.; Gambhir, S. S. Noninvasive molecular imaging of small 
living subjects using raman spectroscopy. Proc. Natl. Acad. 
Sci. USA 2008, 105, 5844–5849. 
[14]  Smith, A. M.; Mancini, M. C.; Nie, S. Bioimaging: Second 
window for in vivo imaging. Nat. Nanotechnol. 2009, 4, 
710–711. 
[15]  Welsher, K.; Liu, Z.; Sherlock, S. P.; Robinson, J. T.; Chen, 
Z.; Daranciang, D.; Dai, H. A route to brightly fluorescent 
carbon nanotubes for near-infrared imaging in mice. Nat. 
Nanotechnol. 2009, 4, 773–780. 
[16]  Perrault, S. D.; Walkey, C.; Jennings, T.; Fischer, H. C.; 
Chan, W. C. W. Mediating tumor targeting efficiency of nano- 
particles through design. Nano Lett. 2009, 9, 1909– 1915. 
[17]  Eghtedari, M.; Oraevsky, A.; Copland, J. A.; Kotov, N. A.; 
Conjusteau, A.; Motamedi, M. High sensitivity of in vivo 
detection of gold nanorods using a laser optoacoustic imaging 
system. Nano Lett. 2007, 7, 1914–1918. 
[18]  Kim, J. -W.; Galanzha, E. I.; Shashkov, E. V.; Moon, H. -M.; 
Zharov, V. P. Golden carbon nanotubes as multimodal 
photoacoustic and photothermal high-contrast molecular 
agents. Nat. Nanotechnol. 2009, 4, 688–694. 
[19]  De La Zerda, A.; Zavaleta, C.; Keren, S.; Vaithilingam, S.; 
Bodapati, S.; Liu, Z.; Levi, J.; Smith, B. R.; Ma, T. -J.; Oralkan, 
O., et al. Carbon nanotubes as photoacoustic molecular 
imaging agents in living mice. Nat. Nanotechnol. 2008, 3, 
557–562. 
[20]  Aubin, J. E. Autofluorescence of viable cultured mammalian 
cells. J. Histochem. Cytochem. 1979, 27, 36–43. 
[21]  O’Neal, D. P.; Hirsch, L. R.; Halas, N. J.; Payne, J. D.; 
West, J. L. Photo-thermal tumor ablation in mice using near 
infrared-absorbing nanoparticles. Cancer Lett. 2004, 209, 
171–176. 
[22]  Sassaroli, E.; Li, K. C. P.; O’Neill, B. E. Numerical 
investigation of heating of a gold nanoparticle and the 
surrounding microenvironment by nanosecond laser pulses 
for nanomedicine applications. Phys. Med. Biol. 2009, 54, 
5541–5560. 
[23]  Stern, J. M.; Stanfield, J.; Kabbani, W.; Hsieh, J. -T.; Cadeddu, 
J. A. Selective prostate cancer thermal ablation with laser 
activated gold nanoshells. J. Urology 2008, 179, 748–753. 
[24]  Terentyuk, G. S.; Maslyakova, G. N.; Suleymanova, L. V.; 
Khlebtsov, N. G.; Khlebtsov, B. N.; Akchurin, G. G.; 
Maksimova, I. L.; Tuchin, V. V. Laser-induced tissue 
hyperthermia mediated by gold nanoparticles: Toward 
cancer phototherapy. J. Biomed. Opt. 2009, 14, 021016. 
[25]  Huang, X.; Jain, P.; El-Sayed, I.; El-Sayed, M. Plasmonic 
photothermal therapy (pptt) using gold nanoparticles. Laser 
Med. Sci. 2008, 23, 217–228. 
Nano Res 
 
15
[26]  von Maltzahn, G.; Park, J.-H.; Agrawal, A.; Bandaru, N. K.; 
Das, S. K.; Sailor, M. J.; Bhatia, S. N. Computationally 
guided photothermal tumor therapy using long-circulating 
gold nanorod antennas. Cancer Res. 2009, 69, 3892–3900. 
[27]  Huff, T. B.; Tong, L.; Zhao, Y.; Hansen, M. N.; Cheng, 
J. -X.; Wei, A. Hyperthermic effects of gold nanorods on 
tumor cells. Nanomedicine-UK 2007, 2, 125–132. 
[28]  Dickerson, E. B.; Dreaden, E. C.; Huang, X.; El-Sayed, I. 
H.; Chu, H.; Pushpanketh, S.; McDonald, J. F.; El-Sayed, 
M. A. Gold nanorod assisted near-infrared plasmonic photo- 
thermal therapy (pptt) of squamous cell carcinoma in mice. 
Cancer Lett. 2008, 269, 57–66. 
[29]  Hasan, W.; Stender, C. L.; Lee, M. H.; Nehl, C. L.; Lee, J.; 
Odom, T. W. Tailoring the structure of nanopyramids for 
optimal heat generation. Nano Lett. 2009, 9, 1555–1558. 
[30]  Ghosh, S.; Dutta, S.; Gomes, E.; Carroll, D.; D’Agostino, R.; 
Olson, J.; Guthold, M.; Gmeiner, W. H. Increased heating 
efficiency and selective thermal ablation of malignant tissue 
with DNA-encased multiwalled carbon nanotubes. ACS 
Nano 2009, 3, 2667–2673. 
[31]  Gannon, C. J.; Cherukuri, P.; Yakobsen, B. I. ; Cognet, L.; 
Kanzius, J. S.; Kittrell, C.; Weisman, R. B.; Pasquali, M.; 
Schmidt, H. K.; Smalley, R. E.; Curley, S. A. Carbon 
nanotube-enhanced thermal destruction of cancer cells in a 
noninvasive radiofrequency field. Cancer 2007, 110, 2654– 
2665. 
[32]  Xiao, Y.; Gao, X.; Taratula, O.; Treado, S.; Urbas, A.; 
Holbrook, R. D.; Cavicchi, R.; Avedisian, C. T.; Mitra, S.; 
Savla, R., et al. Anti-her2 igy antibody-functionalized single- 
walled carbon nanotubes for detection and selective destruction 
of breast cancer cells. BMC Cancer 2009, 9, 351. 
[33]  Zhou, F.; Xing, D.; Ou, Z.; Wu, B.; Resasco, D. E.; Chen, 
W. R. Cancer photothermal therapy in the near-infrared 
region by using single-walled carbon nanotubes. J. Biomed. 
Opt. 2009, 14, 021009. 
[34]  Prencipe, G.; Tabakman, S. M.; Welsher, K.; Liu, Z.; 
Goodwin, A. P.; Zhang, L.; Henry, J.; Dai, H. PEG branched 
polymer for functionalization of nanomaterials with ultralong 
blood circulation. J. Am. Chem. Soc. 2009, 131, 4783–4787. 
[35]  Liu, Z.; Tabakman, S. M.; Chen, Z.; Dai, H. Preparation of 
carbon nanotube bioconjugates for biomedical applications. 
Nat. Protoc. 2009, 4, 1372–1381. 
[36]  O’Connell, M. J.; Bachilo, S. M.; Huffman, C. B.; Moore, 
V. C.; Strano, M. S.; Haroz, E. H.; Rialon, K. L.; Boul, P. J.; 
Noon, W. H.; Kittrell, C., et al. Band gap fluorescence from 
individual single-walled carbon nanotubes. Science 2002, 
297, 593–596. 
[37]  Nikoobakht, B.; El-Sayed, M. A. Preparation and growth 
mechanism of gold nanorods (NRs) using seed-mediated 
growth method. Chem. Mater. 2003, 15, 1957–1962. 
[38]  Liu, Z.; Davis, C.; Cai, W.; He, L.; Chen, X.; Dai, H. 
Circulation and long-term fate of functionalized, biocompatible 
single-walled carbon nanotubes in mice probed by raman 
spectroscopy. Proc. Natl. Acad. Sci. USA 2008, 105, 1410– 
1415. 
[39]  Lee, J. H.; Sherlock, S. P.; Masahiro, T.; Hisanori, K.; 
Suzuki, Y.; Goodwin, A.; Robinson, J.; Seo, W.S.; Liu, Z.; 
Luong, R., et al. High-contrast in vivo visualization of 
microvessels using novel feco/gc magnetic nanocrystals. 
Magn. Reson. Med. 2009, 62, 1497–1509. 
[40]  Schwartz, J. A.; Shetty, A. M.; Price, R. E.; Stafford, R. J.; 
Wang, J. C.; Uthamanthil, R. K.; Pham, K.; McNichols, R. J.; 
Coleman, C. L.; Payne, J. D. Feasibility study of particle- 
assisted laser ablation of brain tumors in orthotopic canine 
model. Cancer Res. 2009, 69, 1659–1667. 
[41]  Jain, P. K.; Lee, K. S.; El-Sayed, I. H.; El-Sayed, M. A. 
Calculated absorption and scattering properties of gold 
nanoparticles of different size, shape, and composition: 
Applications in biological imaging and biomedicine. J. 
Phys. Chem. B 2006, 110, 7238–7248. 
[42]  Schipper, M. L.; Nakayama-Ratchford, N.; Davis, C. R.; 
Kam, N. W. S.; Chu, P.; Liu, Z.; Sun, X.; Dai, H.; Gambhir, 
S. S. A pilot toxicology study of single-walled carbon 
nanotubes in a small sample of mice. Nat. Nanotechnol. 
2008, 3, 216–221. 
[43]  Day, E. S.; Morton, J. G.; West, J. L. Nanoparticles for 
thermal cancer therapy. J. Biomech. Eng. -T ASME 2009, 131, 
074001. 
[44]  Wang, S.; Lu, W.; Tovmachenko, O.; Rai, U. S.; Yu, H.; 
Ray, P. C. Challenge in understanding size and shape 
dependent toxicity of gold nanomaterials in human skin 
keratinocytes. Chem. Phys. Lett. 2008, 463, 145–149. 
